drugset / Trial / NCT03707899
The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers.
Timeline
- Start
- 2018-12-13
- Primary completion
- 2019-02-18
- Completion
- 2019-05-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | — |
| Subject | Rosuvastatin | Small molecule | 5 mg | — |
| Subject | Telmisartan | Other / unclassified | 80 mg | — |